NCT05875116 Virtual Reality Versus Constraint-induced Movement on Hemiparesis in Cerebrovascular Event
| NCT ID | NCT05875116 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Coordinación de Investigación en Salud, Mexico |
| Condition | Stroke Sequelae |
| Study Type | INTERVENTIONAL |
| Enrollment | 119 participants |
| Start Date | 2018-08-17 |
| Primary Completion | 2024-08-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 119 participants in total. It began in 2018-08-17 with a primary completion date of 2024-08-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this clinical trial is to measure the effect of Rehabilitation with Virtual Reality or Modified Constraint-Induced Movement Therapy on hemiparesis in patients with Cerebral Vascular Event. The question to be answered is: What is the effect of different therapeutic modalities supported by Virtual Reality or Modified Constraint-Induced Movement Therapy compared with usual Physical and Occupational Therapy on motor recovery of paretic limbs in patients with Cerebrovascular Event? The patients will carry out activities of: * Virtual reality or * Movement Restriction-Induction Therapy. The investigators will compare the changes in the functionality of the paretic hemibody with a group undergoing regular physical and occupational therapy, as well as language and treatment-related satisfaction.
Eligibility Criteria
Inclusion Criteria: * Adult patients between 35 and 70 years of age and with a clinically and tomographically proven diagnosis of a cerebral vascular event in the territory of the middle cerebral artery. * Patients with hemiparesis secondary to the cerebrovascular event * Patients with a maximum Ashworth of 2 and Brunnstrom of minimum 4 * Patients with or without aphasia * Patients with evolution between 1 to 3 months from hospital discharge of the cerebrovascular event * Patients with cerebrovascular event of any sex * Patients with vascular event without cognitive deficit * Patients who agree to participate by signing an informed consent, by them or their family member or person in charge. Exclusion Criteria: * Patients who develop dementia or neurological-psychomotor complications during the study. * Patients who present a new cerebrovascular event during the investigation * Patients who do not complete at least 90% of the program * Patients in whom a lack of family support or secondary gain is detected.
Contact & Investigator
María del Carmen Rojas-Sosa, Doctorado
PRINCIPAL INVESTIGATOR
Instituto Mexicano del Seguro Social
Frequently Asked Questions
Who can join the NCT05875116 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 70 Years, studying Stroke Sequelae. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05875116 currently recruiting?
Yes, NCT05875116 is actively recruiting participants. Contact the research team at juan.gardunoe@gmail.com for enrollment information.
Where is the NCT05875116 trial being conducted?
This trial is being conducted at Mexico City, Mexico.
Who is sponsoring the NCT05875116 clinical trial?
NCT05875116 is sponsored by Coordinación de Investigación en Salud, Mexico. The principal investigator is María del Carmen Rojas-Sosa, Doctorado at Instituto Mexicano del Seguro Social. The trial plans to enroll 119 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.